Q4 2025 net product revenue for ZORYVE® (roflumilast) was $127.5 million, an 84% increase compared to Q4 2024, and a 29% increase compared to Q3 2025Full year 2025 net product ...
Richard R. Redfern, M.S., C.P.G. No. 10717, an independent Consulting Geologist for Fairchild and a "qualified person" as defined in NI 43-101, has reviewed and approved the scientific and technical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results